The fact
The clinical study shows a significant reduction in migraine days among treated patients.
This data could speed up regulatory approval processes in Europe and the United States.
Click the link to read an article on the topic:
The clinical study shows a significant reduction in migraine days among treated patients.
This data could speed up regulatory approval processes in Europe and the United States.